• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

产生对β-内酰胺酶抑制剂耐药的多个TEM突变体的大肠杆菌临床分离株。

Clinical isolates of Escherichia coli producing multiple TEM mutants resistant to beta-lactamase inhibitors.

作者信息

Sirot D, Chanal C, Henquell C, Labia R, Sirot J, Cluzel R

机构信息

Clermont-Ferrand, France.

出版信息

J Antimicrob Chemother. 1994 Jun;33(6):1117-26. doi: 10.1093/jac/33.6.1117.

DOI:10.1093/jac/33.6.1117
PMID:7928805
Abstract

Twenty clinical isolates of Escherichia coli resistant to amoxycillin and ticarcillin, both in combination with clavulanic acid, were studied. The ranges of MICs for these strains as determined by the agar dilution method were as follows: amoxycillin, 2048- > 4096 mg/L; ticarcillin, 512- > 4096 mg/L; piperacillin, 32-256 mg/L; mecillinam, 0.5-8 mg/L; and cephalothin 4-16 mg/L. Combining amoxycillin with beta-lactamase inhibitors, each at a fixed concentration of 4 mg/L, had only modest potentiating effects on the activities of this agent, the ranges of MICs falling to 256- > 2048 mg/L in the presence of clavulanic acid or sulbactam and to 64-1024 mg/L and 128-2048 mg/L in the presence of tazobactam and brobactam respectively. The pI values for the beta-lactamases produced by the 20 isolates were 5.2 for 15 strains, 5.4 for four strains and 7.4 for a single strain. Colony hybridization with oligonucleotides was performed in order to detect substitutions of arginine at position 241 (Arg-241) and methionine at position 67 (Met-67). Based on this technique, the four beta-lactamases with pI values of 5.4 were grouped into two oligotypes (+ = hybridization, - = non-hybridization)-Arg-241+, Met-67- (n = 3) and Arg-241+, Met-67+ (n = 1); in one of the three mutants which did not hybridize with the Met-67 probe, leucine had been substituted for methionine at position 67. The beta-lactamases with pI values of 5.2 which were identified in 15 strains were grouped into the following three oligotypes: Arg-241-, Met-67+ (n = 7); Arg-241-, Met-67- (n = 6); and Arg-241+, Met-67- (n = 2). In three of the 13 mutants which failed to hybridize with the Arg-241 probe, serine residues had replaced arginine residues at position 241. Substitutions of Arg-241 or Met-67 led to reduced affinities of the mutant enzymes for the beta-lactams tested. The results of the hybridization studies demonstrate that, amongst E. coli clinical isolates, there is a diversity of mutant TEM enzymes mediating resistance to beta-lactamase inhibitors.

摘要

对20株对阿莫西林和替卡西林(二者均与克拉维酸联合使用)耐药的大肠埃希菌临床分离株进行了研究。通过琼脂稀释法测定,这些菌株的最低抑菌浓度(MIC)范围如下:阿莫西林,2048~>4096mg/L;替卡西林,512~>4096mg/L;哌拉西林,32~256mg/L;美西林,0.5~8mg/L;头孢噻吩,4~16mg/L。将阿莫西林与β-内酰胺酶抑制剂各以4mg/L的固定浓度联合使用时,对该药物活性仅有适度的增强作用,在克拉维酸或舒巴坦存在时MIC范围降至256~>2048mg/L,在他唑巴坦和溴巴坦存在时分别降至64~1024mg/L和128~2048mg/L。20株分离株产生的β-内酰胺酶的pI值,15株为5.2,4株为5.4,1株为7.4。进行了寡核苷酸菌落杂交,以检测第241位精氨酸(Arg-241)和第67位甲硫氨酸(Met-67)的取代情况。基于该技术,4株pI值为5.4的β-内酰胺酶被分为两种寡核苷酸类型(+ =杂交,- =非杂交)——Arg-241+,Met-67-(n = 3)和Arg-241+,Met-67+(n = 1);在3株未与Met-67探针杂交的突变体中,有1株在第67位甲硫氨酸被亮氨酸取代。在15株中鉴定出的pI值为5.2的β-内酰胺酶被分为以下三种寡核苷酸类型:Arg-241-,Met-67+(n = 7);Arg-241-,Met-67-(n = 6);和Arg-241+,Met-67-(n = 2)。在13株未与Arg-241探针杂交的突变体中,有3株在第241位丝氨酸残基取代了精氨酸残基。Arg-241或Met-67的取代导致突变酶对所测试的β-内酰胺类药物的亲和力降低。杂交研究结果表明,在大肠埃希菌临床分离株中,存在多种介导对β-内酰胺酶抑制剂耐药的突变TEM酶。

相似文献

1
Clinical isolates of Escherichia coli producing multiple TEM mutants resistant to beta-lactamase inhibitors.产生对β-内酰胺酶抑制剂耐药的多个TEM突变体的大肠杆菌临床分离株。
J Antimicrob Chemother. 1994 Jun;33(6):1117-26. doi: 10.1093/jac/33.6.1117.
2
Susceptibility of Escherichia coli isolates with TEM-1 beta-lactamase to combinations of BRL42715, tazobactam or clavulanate with piperacillin or amoxycillin .产TEM-1β-内酰胺酶的大肠杆菌分离株对BRL42715、他唑巴坦或克拉维酸与哌拉西林或阿莫西林联合用药的敏感性
J Antimicrob Chemother. 1991 Jun;27(6):761-7. doi: 10.1093/jac/27.6.761.
3
Comparative in vitro activities of amoxicillin-clavulanate, ampicillin-sulbactam and piperacillin-tazobactam against strains of Escherichia coli and proteus mirabilis harbouring known beta-lactamases.阿莫西林-克拉维酸、氨苄西林-舒巴坦和哌拉西林-他唑巴坦对携带已知β-内酰胺酶的大肠杆菌和奇异变形杆菌菌株的体外比较活性。
Infection. 1991 Mar-Apr;19(2):106-9. doi: 10.1007/BF01645578.
4
[Resistance to amoxicillin and amoxicillin-clavulanic acid combination of 231 clinical strains of Escherichia coli, isolated in 1992 at the Cochin Hospital].[1992年在科钦医院分离的231株临床大肠杆菌对阿莫西林及阿莫西林-克拉维酸组合的耐药性]
Pathol Biol (Paris). 1995 Nov;43(9):760-5.
5
[Bactericidal activity of combinations of ticarcillin-clavulanic acid or other beta-lactams (amoxicillin, piperacillin-tazobactam, ticarcillin) with gentamicin against Enterococcus faecalis and E. faecium].替卡西林-克拉维酸或其他β-内酰胺类抗生素(阿莫西林、哌拉西林-他唑巴坦、替卡西林)与庆大霉素联合使用对粪肠球菌和屎肠球菌的杀菌活性
Pathol Biol (Paris). 1995 Apr;43(4):245-52.
6
Activity of beta-lactamase inhibitor combinations on Escherichia coli isolates exhibiting various patterns of resistance to beta-lactam agents.β-内酰胺酶抑制剂组合对表现出对β-内酰胺类药物不同耐药模式的大肠杆菌分离株的活性。
Eur J Clin Microbiol Infect Dis. 1995 Nov;14(11):972-8. doi: 10.1007/BF01691379.
7
Emergence of clinical isolates of Escherichia coli producing TEM-1 derivatives or an OXA-1 beta-lactamase conferring resistance to beta-lactamase inhibitors.产生TEM-1衍生物或对β-内酰胺酶抑制剂耐药的OXA-1β-内酰胺酶的大肠杆菌临床分离株的出现。
Antimicrob Agents Chemother. 1994 May;38(5):1085-9. doi: 10.1128/AAC.38.5.1085.
8
Beta-lactamase production in members of the family Enterobacteriaceae and resistance to beta-lactam-enzyme inhibitor combinations.肠杆菌科细菌中β-内酰胺酶的产生及对β-内酰胺酶抑制剂联合制剂的耐药性。
Antimicrob Agents Chemother. 1990 Apr;34(4):622-7. doi: 10.1128/AAC.34.4.622.
9
Selection of variants of the TEM-1 beta-lactamase, encoded by a plasmid of clinical origin, with increased resistance to beta-lactamase inhibitors.筛选由临床来源质粒编码的、对β-内酰胺酶抑制剂耐药性增强的TEM-1β-内酰胺酶变体。
J Antimicrob Chemother. 1993 May;31(5):655-64. doi: 10.1093/jac/31.5.655.
10
Incidence and mechanisms of resistance to the combination of amoxicillin and clavulanic acid in Escherichia coli.大肠杆菌对阿莫西林与克拉维酸联合用药的耐药发生率及机制
Antimicrob Agents Chemother. 1995 Nov;39(11):2478-83. doi: 10.1128/AAC.39.11.2478.

引用本文的文献

1
Early treatment response to piperacillin/tazobactam in patients with bloodstream infections caused by non-ESBL ampicillin/sulbactam-resistant Escherichia coli: a binational cohort study.哌拉西林/他唑巴坦治疗非产 ESBL 氨苄西林/舒巴坦耐药大肠埃希菌血流感染患者的早期治疗反应:一项跨国队列研究。
Infection. 2023 Dec;51(6):1749-1758. doi: 10.1007/s15010-023-02074-z. Epub 2023 Jul 18.
2
Phenotypic and Genomic Characterization of AmpC-Producing Klebsiella pneumoniae From Korea.韩国产产 AmpC 酶肺炎克雷伯菌的表型和基因组特征
Ann Lab Med. 2018 Jul;38(4):367-370. doi: 10.3343/alm.2018.38.4.367.
3
Spanish multicenter study of the epidemiology and mechanisms of amoxicillin-clavulanate resistance in Escherichia coli.
西班牙多中心研究大肠杆菌中产β-内酰胺酶株对阿莫西林-克拉维酸耐药的流行病学和机制
Antimicrob Agents Chemother. 2012 Jul;56(7):3576-81. doi: 10.1128/AAC.06393-11. Epub 2012 Apr 9.
4
Clinical characteristics of bloodstream infections due to ampicillin-sulbactam-resistant, non-extended- spectrum-beta-lactamase-producing Escherichia coli and the role of TEM-1 hyperproduction.产超广谱β-内酰胺酶阴性氨苄西林-舒巴坦耐药大肠埃希菌血流感染的临床特征及 TEM-1 过度表达的作用。
Antimicrob Agents Chemother. 2011 Feb;55(2):495-501. doi: 10.1128/AAC.00797-10. Epub 2010 Dec 6.
5
Molecular and biochemical characterization of the natural chromosome-encoded class A beta-lactamase from Pseudomonas luteola.从黄假单胞菌中天然染色体编码的 A 类β-内酰胺酶的分子和生化特性分析。
Antimicrob Agents Chemother. 2010 Jan;54(1):45-51. doi: 10.1128/AAC.00427-09. Epub 2009 Nov 2.
6
TEM-89 beta-lactamase produced by a Proteus mirabilis clinical isolate: new complex mutant (CMT 3) with mutations in both TEM-59 (IRT-17) and TEM-3.奇异变形杆菌临床分离株产生的TEM-89β-内酰胺酶:一种新型复合突变体(CMT 3),在TEM-59(IRT-17)和TEM-3中均有突变。
Antimicrob Agents Chemother. 2001 Dec;45(12):3591-4. doi: 10.1128/AAC.45.12.3591-3594.2001.
7
A novel CTX-M beta-lactamase (CTX-M-8) in cefotaxime-resistant Enterobacteriaceae isolated in Brazil.在巴西分离出的对头孢噻肟耐药的肠杆菌科细菌中发现的一种新型CTX-Mβ-内酰胺酶(CTX-M-8)。
Antimicrob Agents Chemother. 2000 Jul;44(7):1936-42. doi: 10.1128/AAC.44.7.1936-1942.2000.
8
Diversity of TEM mutants in Proteus mirabilis.奇异变形杆菌中透射电子显微镜(TEM)突变体的多样性。
Antimicrob Agents Chemother. 1999 Nov;43(11):2671-7. doi: 10.1128/AAC.43.11.2671.
9
Inhibitor-resistant OXY-2-derived beta-lactamase produced by Klebsiella oxytoca.产酸克雷伯菌产生的耐抑制剂的OXY-2衍生β-内酰胺酶。
Antimicrob Agents Chemother. 1998 Sep;42(9):2184-7. doi: 10.1128/AAC.42.9.2184.
10
Chromosomally encoded ampC-type beta-lactamase in a clinical isolate of Proteus mirabilis.奇异变形杆菌临床分离株中的染色体编码AmpC型β-内酰胺酶
Antimicrob Agents Chemother. 1998 May;42(5):1110-4. doi: 10.1128/AAC.42.5.1110.